Literature DB >> 8799074

Ross River virus infection on the North Coast of New South Wales.

V J Westley-Wise1, J R Beard, T J Sladden, T M Dunn, J Simpson.   

Abstract

A retrospective follow-up survey was undertaken of residents of the North Coast of New South Wales infected with Ross River virus in 1992. The aims of the study were to describe the epidemiology and acute symptomatology of Ross River virus infection, its natural history during the first 12 months of infection, and its effects on those infected. Questionnaires were distributed to both cases and their medical practitioners. Of 129 people infected, aged between six and 85 years, 81 (63 per cent) were male and 48 (37 per cent) were female. The peak age-specific incidence was in the age group 50 to 59 years. The most common symptoms were arthralgia (95 per cent) and tiredness (91 per cent). Over 60 per cent took time off work. At 12 months follow-up, over 50 per cent reported persistent arthralgia, 35 per cent reported persistent tiredness and 15 per cent were still unable to carry out their normal activities. The median duration of symptoms was in the range 7 to 12 months, and of incapacity was in the range five weeks to three months. There were some differences from previous reports of Ross River virus outbreaks, in the incidence of major symptoms and the duration of illness and incapacity. These are likely to be at least partly due to inconsistent measurement methods. In this study, there were systematic differences between medical practitioners' and patients' estimates of periods of incapacity. Previous estimates of the direct economic costs and indirect human costs of infection based on data obtained from medical practitioners, although alarming, are almost certainly underestimates.

Entities:  

Mesh:

Year:  1996        PMID: 8799074     DOI: 10.1111/j.1467-842x.1996.tb01343.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

1.  Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.

Authors:  Kristina A Stoermer; Adam Burrack; Lauren Oko; Stephanie A Montgomery; Luke B Borst; Ronald G Gill; Thomas E Morrison
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

Review 2.  Ross River virus transmission, infection, and disease: a cross-disciplinary review.

Authors:  D Harley; A Sleigh; S Ritchie
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Predictive modelling of Ross River virus notifications in southeastern Australia.

Authors:  Z Cutcher; E Williamson; S E Lynch; S Rowe; H J Clothier; S M Firestone
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

4.  Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.

Authors:  Laura A Powell; Julie M Fox; Nurgun Kose; Arthur S Kim; Mahsa Majedi; Robin Bombardi; Robert H Carnahan; James C Slaughter; Thomas E Morrison; Michael S Diamond; James E Crowe
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

5.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10

Review 6.  Ross River Virus Infection: A Cross-Disciplinary Review with a Veterinary Perspective.

Authors:  Ka Y Yuen; Helle Bielefeldt-Ohmann
Journal:  Pathogens       Date:  2021-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.